Literature DB >> 16741157

Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.

Clifford D L Folmes1, Alexander S Clanachan, Gary D Lopaschuk.   

Abstract

The cardioprotective effect of insulin during ischemia-reperfusion has been associated with stimulation of glucose uptake and glycolysis. Although fatty acids and 5'-AMP activated protein kinase (AMPK) are regulators of glucose metabolism, it is unknown what effect insulin has on postischemic function and AMPK activity in the presence of high levels of fatty acid. Isolated ejecting mouse hearts were perfused with Krebs-Henseleit solution containing 5 mmol x L(-1) glucose and 0, 0.2, or 1.2 mmol x L(-1) palmitate, with or without 100 microU/mL insulin. During aerobic perfusion in the absence of palmitate, insulin stimulated glycolysis by 73% and glucose oxidation by 54%, while inhibiting AMPK activity by 43%. In the presence of 0.2 or 1.2 mmol x L(-1) palmitate, insulin stimulated glycolysis by 111% and 105% and glucose oxidation by 72% and 274% but no longer inhibited AMPK activity. During reperfusion of hearts in the absence of palmitate, insulin increased recovery of cardiac power by 47%. This was associated with a 97% increase in glycolysis and a 160% increase in glucose oxidation. However, in the presence of 1.2 mmol x L(-1) palmitate, insulin now decreased recovery of cardiac power by 42%. During reperfusion, glucose oxidation was inhibited by high fat, but insulin-stimulated glycolysis remained high, resulting in increased proton production. In the absence of fatty acids, insulin blunted the ischemia-induced activation of AMPK, but this effect was lost in the presence of fatty acids. We demonstrate that the cardioprotective effect of insulin and its ability to inhibit AMPK activity are lost in the presence of high concentrations of fatty acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741157     DOI: 10.1161/01.RES.0000229656.05244.11

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

Review 1.  Diabetic cardiomyopathy: signaling defects and therapeutic approaches.

Authors:  Joseph S Dobrin; Djamel Lebeche
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-03

2.  Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio.

Authors:  Qingqing Liu; Marie-Soleil Gauthier; Lei Sun; Neil Ruderman; Harvey Lodish
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

3.  Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia.

Authors:  Qianwen Wang; Rajakumar V Donthi; Jianxun Wang; Alex J Lange; Lewis J Watson; Steven P Jones; Paul N Epstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 4.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

5.  High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.

Authors:  Anisha A Gupte; Laurie J Minze; Maricela Reyes; Yuelan Ren; Xukui Wang; Gerd Brunner; Mohamad Ghosn; Andrea M Cordero-Reyes; Karen Ding; Domenico Pratico; Joel Morrisett; Zheng-Zheng Shi; Dale J Hamilton; Christopher J Lyon; Willa A Hsueh
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

Review 6.  Metabolic reserve of the heart: the forgotten link between contraction and coronary flow.

Authors:  Christos Kassiotis; Mitra Rajabi; Heinrich Taegtmeyer
Journal:  Prog Cardiovasc Dis       Date:  2008 Jul-Aug       Impact factor: 8.194

7.  Transient activation of p38 MAP kinase and up-regulation of Pim-1 kinase in cardiac hypertrophy despite no activation of AMPK.

Authors:  Biao Lei; David J Chess; Wendy Keung; Karen M O'Shea; Gary D Lopaschuk; William C Stanley
Journal:  J Mol Cell Cardiol       Date:  2008-07-01       Impact factor: 5.000

8.  Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.

Authors:  Karin Kaiserova; Xian-Liang Tang; Sanjay Srivastava; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2008-01-27       Impact factor: 5.157

Review 9.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  Acute regulation of 5'-AMP-activated protein kinase by long-chain fatty acid, glucose and insulin in rat primary adipocytes.

Authors:  Abdel Hebbachi; David Saggerson
Journal:  Biosci Rep       Date:  2012-12-13       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.